Bizarre Patents
A small umbrella which may be removably attached to a beverage container in order to shade the beverage container from the direct rays of the sun.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110305758 | ORALLY DISINTEGRATING TABLET HAVING INNER CORE The present invention provides an orally disintegrating tablet with improved photostability of a medicament unstable to light. The orally disintegrating tablet has an inner core and an outer layer that covers the surface of the inner core, wherein the inner core contain... | 12/15/2011 |
| 20110280941 | COMPOSITIONS OF PROTON PUMP INHIBITORS AND INSULIN SECRETAGOGUES, AND METHODS OF THEIR USE TO TREAT DIABETES The present invention relates to compositions, kits and methods of treating diabetes. More specifically, compositions of at least one proton pump inhibitor and at least one insulin secretagogue, kits and methods of their use to treat diabetes.... | 11/17/2011 |
| 20110280940 | Di-Vanilloyl And Tri-Vanilloyl Derivatives For Use In Anti-Cancer Therapy The invention relates to the medical field, more precisely in the field of anti-cancer treatment and treatment of Alzheimer's disease, Parkinson's disease or Pick's disease or for ameliorating symptoms of Down syndrome, providing newly synthesised multi-vanilloyl deriva... | 11/17/2011 |
| 20110250273 | COMPOSITIONS OF PROTON PUMP INHIBITORS, KITS AND METHODS OF THEIR USE TO TREAT DIABETES The present invention relates to compositions, kits and methods of treating diabetes. More specifically, compositions of at least one proton pump inhibitor, kits and methods of their use to treat diabetes.... | 10/13/2011 |
| 20110236482 | Composition For The Prevention And Treatment Of Viral Infections The invention relates to a composition comprising an extract of the genus Ribes for use in the prophylaxis and/or treatment of viral infections. In particular, the composition can be used for the prophylaxis and/or treatment of the symptoms of influenza, common c... | 09/29/2011 |
| 20110229571 | Pharmaceutical Compositions Comprising a Selective I1 Imidazoline Receptor Agonist and an Angiotensin II Receptor Blocker Pharmaceutical compositions containing selective imidazoline receptor agonists combined with angiotensin II receptor blockers, particularly, pharmaceutical compositions containing Moxonidine and Eprosartan mesylate, as well as the use of such compositions for the treatm... | 09/22/2011 |
| 20110206765 | Non-Typeable Haemophilus Influenzae Vaccines and Their Uses Provided are non-typeable Haemophilus influenzae vaccines useful for the treatment of chronic obstructive pulmonary disease and asthma in a patient. In certain aspects, the vaccine is a monobacterial vaccine. Bacterial strains for use in the vaccines of the prese... | 08/25/2011 |
| 20110200668 | PHARMACEUTICAL COMPOSITION FOR PREVENTING DYSBIOSIS ASSOCIATED WITH ENTERAL ADMINISTRATION OF ANTIBIOTICS In the first variant, the pharmaceutical composition comprises antibiotic and prebiotic in the form of oligosaccharide of a group comprising fructooligosaccharides, galactooligosaccharides, maltooligosaccharides and isomaltooligosaccharides the polymerisation degree of ... | 08/18/2011 |
| 20110195121 | CHRONOTHERAPEUTIC PHARMACEUTICAL DOSAGE FORM This invention relates to a pharmaceutical dosage form for the phase-controlled and chronotherapeutic delivery of at least one and, preferably, several pharmaceutically active ingredients. The dosage form has a carrier platform which,—preferably, is a polymer having k... | 08/11/2011 |
| 20110189280 | DOSAGE FORM COMPRISING 1-ISOPROPYL-4-HEXAHYDRO-1H-1,4-DIAZEPINE OR A SALT THEREOF The invention relates to a dosage form for oral administration comprising a carrier tablet, wherein the carrier tablet is at least partially (preferably partially) covered by a film comprising 1-isopropyl-4-{[4-(tetrahydro-2H-pyran-4-yloxy)phenyl]carbonyl}hexahydro-1H-1... | 08/04/2011 |
| 20110189283 | APPETISING MEDICAMENTS FOR ORAL ADMINISTRATION IN SOLID FORM FOR PREVENTION AND/OR TREATMENT OF CARDIAC INSUFFICIENCY IN ANIMALS The invention relates to the use of a coating composition for application to a solid veterinary pharmaceutical composition for oral administration for the prevention and/or treatment of cardiac insufficiency in animals, by a method of film coating comprising a powder ap... | 08/04/2011 |
| 20110189271 | PHARMACEUTICAL FORMULATIONS OF ACID-LABILE DRUGS Pharmaceutical formulations comprising inert cores that are coated with a layer comprising an amorphous dexlansoprazole sodium salt formed in-situ, further sequentially coated with an intermediate layer and an enteric coating layer. Coated cores may be further formulate... | 08/04/2011 |
| 20110150989 | Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules ... | 06/23/2011 |
| 20110150992 | QUININE FORMULATIONS, METHOD OF MAKING, AND METHOD OF USE THEREOF Disclosed herein are quinine formulations and methods of using quinine formulations. Specifically disclosed herein are solid oral dosage forms which can be administered as a capsule or tablet, or alternatively as a sprinkle form with the patient experiencing little or n... | 06/23/2011 |
| 20110111026 | HUMIDITY-RESISTANT DRUG FORMULATIONS AND METHODS OF PREPARATION THEREOF The invention relates to a pharmaceutical composition of a humidity-sensitive core comprising an active ingredient or pharmaceutically acceptable salt thereof; a coating over the core, the coating containing a cationic polymer; and an additional coating over the cationi... | 05/12/2011 |
| 20110027356 | Combination of Oral Medicaments Bonded by a Wrapping Oral pharmaceutical dosage form containing at least two medicaments, in which form the medicaments on the one hand are brought together in a leakproof and in-vivo water soluble wrapping and on the other hand are separated so that the active principle of the combined med... | 02/03/2011 |
| 20110020447 | NOVEL DOSAGE FORM The present invention relates to a novel dosage form, to a process for preparing the dosage form and to the use of the dosage form in the treatment of neurological and psychiatric disorders.... | 01/27/2011 |
| 20110014130 | Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing The present invention provides a method for treating a solid dosage form to improve the printability and abrasion resistance of a print to be produced on a surface of the solid dosage form, which includes treating the surface of the solid dosage form with a polyethylene... | 01/20/2011 |
| 20110008432 | Method for Treating a Patient in Need of Aspirin Therapy The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to the patient in need thereof a pharmaceutical composition in unit dosage form comprising aspirin, or a pharm... | 01/13/2011 |
| 20100330179 | Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmac... | 12/30/2010 |
| 20100247649 | PHARMACEUTICAL FORMULATIONS COMPRISING TELMISARTAN AND HYDROCHLOROTHIAZIDE Pharmaceutical tablets comprising a first layer formulated for immediate release of telmisartan from a dissolving matrix and a second layer formulated for immediate release of hydrochlorothiazide from a dissolving matrix, methods for producing tablets and methods of use... | 09/30/2010 |
| 20100233261 | Pharmaceutical Composition Comprising Amlodipine and Losartan Disclosed herein is a pharmaceutical composition comprising a part containing amlodipine or a pharmaceutically acceptable salt thereof and another separate part containing losartan or a pharmaceutically acceptable salt thereof, which exhibits improved preventive and the... | 09/16/2010 |
| 20100226855 | Rate-Controlled Oral Dosage Formulations The present invention relates to a drug delivery system, in which a drug containing core, either alone or coated with a rate controlling membrane system, is enveloped on its circumference by an optionally bioadhesive coating, thereby yielding a monolithic system that al... | 09/09/2010 |
| 20100221445 | O-DESMETHYLVENLAFAXINE AND BAZEDOXIFENE COMBINATION PRODUCT AND USES THEREOF A combination product containing at least two active compounds, O-desmethylvenlafaxine or a pharmaceutically acceptable salt thereof and bazedoxifene or a pharmaceutically acceptable salt thereof is described. Also described are methods of making and using this combinat... | 09/02/2010 |
| 20100221338 | Coated Tablets Of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine And Methods For Measuring Effectiveness Of Coating Coated tablets of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are provided. The tablets minimize the perceived bitterness of the medicament. A method for analyzing instantaneous dissolution of sub-microgra... | 09/02/2010 |
| 20100189790 | Delayed release rasagiline formulation Disclosed are formulations which are designed to delay release of rasagiline while maintaining specific pharmacokinetic properties.... | 07/29/2010 |
| 20100172987 | Three Layer Tablet Containing Cetirizine, Pseudoephedrine, and Naproxen In one aspect, the present invention features a tablet including a first drug layer, a second drug layer, and a third drug layer, wherein (i) the first drug layer includes naproxen; (ii) a second drug layer including pseudoephedrine; and (iii) the third drug layer inclu... | 07/08/2010 |
| 20100166861 | PHARMACEUTICAL FORMULATIONS OF SEVALAMER, OR SALTS THEREOF, AND COPOVIDONE The present disclosure provides a pharmaceutical composition for the treatment of hyperphosphatemia in mammals. The composition includes sevelamer and copovidone. The composition is provided in the form of a coated tablet having a compressed core. Also disclosed are met... | 07/01/2010 |
| 20100136111 | PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC AND MISOPROSTOL The present invention relates to pharmaceutical compositions of diclofenac or pharmaceutically acceptable salts thereof and misoprostol or pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparations of such compositions.... | 06/03/2010 |
| 20100112056 | IMMEDIATE RELEASE DOSAGE FORMS OF SODIUM OXYBATE The present invention provides a pharmaceutical composition, presented as a solid unit dosage form adapted for oral administration of sodium oxybate. The preferred unit dosage form is a tablet comprising a relatively high weight-percentage of sodium oxybate, in combinat... | 05/06/2010 |
| 20100074950 | ANTI-DIABETIC COMBINATIONS A pharmaceutical composition comprising a dipeptidyl peptidase IV inhibitor and a slow release biguanide is provided. A method for treating diabetes in a patient in need thereof including administering an anti-diabetic combination comprising a DPP inhibitor and a slow r... | 03/25/2010 |
| 20100068274 | PROCESS FOR PRODUCTION OF TABLET An object of the present invention is to provide a dry coating method which can coat a tablet in a simple manner and with high efficiency, and therefore can produce a tablet having good appearance and hardly causing breaking/cracking. The present invention provides a pr... | 03/18/2010 |
| 20100062064 | Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt the... | 03/11/2010 |
| 20100047349 | Stabilized solid preparation A stabilized solid preparation having stabilized drug content and stabilized appearance, comprising a main ingredient layer and a coating layer formed on the main ingredient layer, wherein the main ingredient layer comprises a granule or a fine particle comprising a sub... | 02/25/2010 |
| 20090269403 | ORAL CONTRACEPTIVE DOSAGE FORMS AND METHODS OF MAKING SUCH DOSAGE FORMS Disclosed herein are oral dosage forms and methods of their use, in particular oral dosage systems for the delivery of drugs for use as a female oral contraceptive. In an embodiment, an oral dosage form includes a progestogen dispersed in an enteric polymer and an estro... | 10/29/2009 |
| 20090226518 | (MONITORING ONLY) COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPELIPIDEMIA ONCE A DAY AT NIGHT The present invention relates to solid pharmaceutical combinations for oral administration comprising nicotinic acid or a nicotinic acid compound or mixtures thereof in an extended release form and an HMG-CoA reductase inhibitor, which are useful for altering lipid leve... | 09/10/2009 |
| 20090220599 | Antifungal formulation and manufacturing method thereof A new antifungal formulation is provided. The present invention uses a sterol modified with polyethylene glycol (PEG) as a drug carrier. The drug carrier encapsulates Amphotericin B (AmB) by self-assembly to form polymeric micelles. The polymeric micelles can reduce tox... | 09/03/2009 |
| 20090220598 | Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists Compositions are described in which certain thyroid hormone receptor-binding compounds are formulated together with either an enteric coating, an antioxidant, or both an enteric coating and an antioxidant. Such formulation acts to prevent the formation of undesired reac... | 09/03/2009 |
| 20090214647 | Compositions For Enternal Application Of Microorganisms The present invention describes a process for the manufacture of a solid composition comprising a microorganism, which process comprises a first step of blending and/or compacting the microorganism with a salt of a medium or long-chain fatty acid to prepare a powderous ... | 08/27/2009 |
| 20090208575 | Pharmaceutical Composition Of Acid Labile Substances A pharmaceutical composition for oral use comprising a) a core comprising an effective amount of benzimidazole and an organic stabilizing agent which is present in an amount effective to stabilize the composition, b) an intermediate layer comprising of a water insoluble... | 08/20/2009 |
